|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/48 |
| (11) | Patento numeris | 2349341 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09748174.1 |
| Europos patento paraiškos padavimo data | 2009-10-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-08-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-10-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/060633 |
| Data | 2009-10-14 |
| (87) | Numeris | WO 2010/045321 |
| Data | 2010-04-22 |
| (30) | Numeris | Data | Šalis |
| 105548 P | 2008-10-15 | US |
| (72) |
MITTERER, Artur, AT
GRANINGER, Michael, AT
HASSLACHER, Meinhard, AT
|
| (73) |
Baxter Healthcare SA,
Thurgauerstrasse 130, 8152 Glattpark (Opfikon),
CH
Baxter International Inc, One Baxter Parkway, Deerfield, IL 60015, US |
| (54) | PEGYLATION OF RECOMBINANT BLOOD COAGULATION FACTORS IN THE PRESENCE OF BOUND ANTIBODIES |
| PEGYLATION OF RECOMBINANT BLOOD COAGULATION FACTORS IN THE PRESENCE OF BOUND ANTIBODIES |